Replies to post #149226 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

"If you are a careful and discerning reader and you go back and review Linda's recent statements, you will see that she has told you all you need to know. JRIII "

Hmm...I must not need to know much.

Where's my ba dum tss?

[GoodGuyBill]

JRIII,

I take issue with your comments and the implication that people who believe as I do-- that NWBO should communicate the P3 OS threshold data, trial and internal investigation status-- "is because it suits some shareholder's urgent timeline to get rich".

If I had an "urgent timeline to get rich", I would have divested in NWBO a long time ago. I have invested in NWBO back in 2013 and have communicated consistently That I would not sell until the end-- before during and after the stock took a fall from $12 to .16! Even today, I still say the same. Though your post may not have been directed at me, I still resent your statement especially since you joined the board in November.

I have little experience in investing and my knowledge in this are is lacking wrt yours. But, fwiw, let me tell you what I do know. On Feb 6, 2017, NWBO PR'd the following:

1. "The PFS events have surpassed the 248-event threshold, but the OS events have not yet reached the 233-event threshold. Based upon the pace of OS events during the last six to eight months, the Company’s current anticipation is that it will be several months until the Trial reaches 233 OS events".

2. "The external parties managing the Trial are now moving forward with the process to reach data lock. In this process, all data from all of the treatment visits and follow up visits for all 331 patients in the Trial, must be subjected to quality control checking. The process involves in-person monitoring visits to all of the 80-plus sites in four countries to review the files onsite, as well as other documentary confirmation and checking of all MRI images. As such, it is a multi-month process. While this process is under way, OS and PFS events will continue to accumulate".

Quote:
PR Link: https://www.nwbio.com/nw-bio-announces-lifting-clinical-hold-dcvax-l-phase-iii-trial-fda-progression-free-survival-events-reached-overall-survival-events-not-yet-reached/

3. Regarding the internal investigation, an NWBO PR, released on 12/08/2015, stated, "The Special Committee anticipates that the investigation will get under way in the coming week and will likely take at least 90 days".

Quote:
PR Link: https://www.nwbio.com/nw-bio-announces-establishment-of-special-committee-and-law-firm-to-conduct-independent-investigation-of-recent-allegations/

So, it is clear that LP/NWBO put this info out there, and by doing so, set the expectations as when these events should likely occur. You say that NWBO, "they have nothing to say". I beg to differ. They have a heck of a lot to say. They know if the internal report has been completed or not. They know if the report vindicates the company or not. The know if the P3 OS threshold has been met or not. They know were we are in the trial approval process. NWBO communicated this initial info AND set the expectations as when these events are likely to occur. The have the info and should communicate it clearly and concisely. The fact they consistently don't give big wall street investors pause to invest and feeds the fire off the shorts.

Thank you, SS. Why is it so hard for some to understand this? The company will not be compelled to issue statements when they have nothing to say. Nor will they be compelled to answer questions because it suits some shareholder's urgent timeline to get rich. That's not how it works, and as someone who spent a career in corporate communications and investor relations, I can assure you that one of the fastest ways a company can get into big trouble is by making public statements when they have nothing to say. If you are a careful and discerning reader and you go back and review Linda's recent statements, you will see that she has told you all you need to know.

[sentiment_stocks]

The company will not be compelled to issue statements when they have nothing to say.

Completely agree. It would make no sense to do that. Or to tell us they have nothing to say.

[flipper44]

Thanks jriii, however, most here don’t have a timeline “to get rich.” Instead, they have waited years for completion of the trial but the goal posts appear to keep moving. 248PFS, 233OS, data maturing, disclosure of interim blinded data. I’m looking for some update regarding what they are meaning as far as the clinical trial status. Many here are very patient investors, Ou has been around a long while, and people are legitimately confused. If an update can bring some clarity, and understanding about the approximate path we are on....is it still data lock at approximately 233 OS for instance? Do you know the answer to that? My guess is no. I would have shut up about this many posts ago, and waited to see if we get something, but the tenor of feedback is quite strong.

[longfellow95]

JRIII.
Agree with most of what you say.
But, I do want to comment on your statement:-

If you are a careful and discerning reader and you go back and review Linda's recent statements, you will see that she has told you all you need to know.

That does come across a touch on the supercilious side.
Are you suggesting that you are sufficiently careful and discerning to have gleaned all you need to know from LP's recent statements. And that anyone with equal care and discernment can do the same?

With the best will in the world, she hasn't told me 'all I need to know.' I'm afraid I'm still stabbing in the dark somewhat.

I'd be very grateful if you could enlighten me about 'all I need to know,' which I'm afraid I don't currently know.